CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2015-12-28
What CHINA PHARMA HOLDINGS, INC. reported in its quarterly report filed 2015-12-28 (fiscal Q2 2015): 34 published measures, 92 facts as tagged in accession 0001010549-15-000420.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-12-28
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001010549-15-000420 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PHARMA HOLDINGS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 115,412,373 | USD | |
| At 2014-12-31 | 121,084,486 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 28,773,102 | USD | |
| At 2014-12-31 | 28,344,366 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 86,639,271 | USD | |
| At 2014-12-31 | 92,740,120 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,127,322 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -6,846,621 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -8,642,950 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -11,033,443 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -515,711 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 2,413,814 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 0 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 5,674,175 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 11,369,105 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 6,130,544 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 13,236,059 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 0 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 605,347 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -264,869 | USD | 181 |
| 2014-01-01 to 2014-06-30 | -4,543,490 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 42,498,895 | USD | |
| At 2014-12-31 | 49,345,516 | USD |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 0.03 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.16 | USD/shares | 181 |
| 2014-04-01 to 2014-06-30 | -0.2 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | -0.25 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 0.03 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.16 | USD/shares | 181 |
| 2014-04-01 to 2014-06-30 | -0.2 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | -0.25 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -19,428 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -38,712 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -19,196 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -38,543 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 38,524,570 | USD | |
| At 2014-12-31 | 43,495,201 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -322,422 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -636,197 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -113,363 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -169,810 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 14,446,027 | USD | |
| At 2014-12-31 | 14,171,838 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -1,494,777 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 7,232,089 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 10,944,616 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 15,941,484 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 13,623,919 | USD | |
| At 2014-12-31 | 15,321,856 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -55,827 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 1,003,300 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 2,417,397 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 5,077,783 | USD | 181 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 4,511,951 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 8,946,657 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 3,713,147 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 8,158,276 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 174,850 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 335,678 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,902,027 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,346,434 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 43,579,557 | shares | |
| At 2014-12-31 | 43,579,557 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 23,590,204 | USD | |
| At 2014-12-31 | 23,590,204 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 32,596,716 | USD | |
| At 2014-12-31 | 33,881,878 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 8,413,910 | USD | |
| At 2014-12-31 | 6,640,718 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 1,154,782 | USD | |
| At 2014-12-31 | 1,317,221 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 253,012 | USD | |
| At 2014-12-31 | 269,870 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,146,750 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -6,807,909 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -8,623,754 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -10,994,900 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -6,846,621 | USD | 181 |
| 2014-01-01 to 2014-06-30 | -11,033,443 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 459,026 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 931,455 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 382,832 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 806,759 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 1,884,749 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 596,819 | USD | 181 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 38,712 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 38,543 | USD | 181 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 0 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 2,508,519 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 4,781,501 | USD | 181 |
Inspect the source
- Entity
- CHINA PHARMA HOLDINGS, INC. / CIK 0001106644
- Captured
- 2026-09-20T05:23:28.377Z
- SEC response SHA-256
ad45dffd15d0f5a098ab8b6912816a8b1b845b1d791781ea412833d3178873c0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001106644.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))